Latest Stories
3 Reasons to Avoid EPC and 1 Stock to Buy Instead
What a brutal six months it’s been for Edgewell Personal Care. The stock has dropped 37.2% and now trades at $16.43, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Sell LOCO and 1 Stock to Buy Instead
El Pollo Loco has been treading water for the past six months, recording a small return of 3.7% while holding steady at $11.33. The stock also fell short of the S&P 500’s 13.4% gain during that period.
3 Reasons to Sell TFC and 1 Stock to Buy Instead
Truist Financial trades at $47.70 and has moved in lockstep with the market. Its shares have returned 17.1% over the last six months while the S&P 500 has gained 13.4%.
3 Reasons to Avoid DOX and 1 Stock to Buy Instead
Over the last six months, Amdocs’s shares have sunk to $77.15, producing a disappointing 17.3% loss - a stark contrast to the S&P 500’s 13.4% gain. This may have investors wondering how to approach the situation.
3 Reasons to Avoid PFBC and 1 Stock to Buy Instead
Preferred Bank has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11% to $94.70 per share while the index has gained 13.4%.
First Bancorp (FBNC): Buy, Sell, or Hold Post Q2 Earnings?
First Bancorp has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.7%. The stock now trades at $51.20, marking a 21% gain. This performance may have investors wondering how to approach the situation.
3 Reasons PMT is Risky and 1 Stock to Buy Instead
PennyMac Mortgage Investment Trust has been treading water for the past six months, recording a small loss of 1.2% while holding steady at $12.58. The stock also fell short of the S&P 500’s 13.4% gain during that period.
Q3 Earnings Outperformers: Teleflex (NYSE:TFX) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers.
Q3 Earnings Highs And Lows: Molson Coors (NYSE:TAP) Vs The Rest Of The Beverages, Alcohol, and Tobacco Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Molson Coors (NYSE:TAP) and its peers.
Q3 Earnings Highlights: Textron (NYSE:TXT) Vs The Rest Of The Aerospace Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at aerospace stocks, starting with Textron (NYSE:TXT).